Molina Healthcare (NYSE:MOH) Stock Rating Upgraded by StockNews.com

Molina Healthcare (NYSE:MOH) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Friday.

MOH has been the topic of several other reports. Truist Financial lowered their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. Stephens reissued an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. Wells Fargo & Company increased their target price on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. Jefferies Financial Group decreased their target price on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research report on Wednesday, July 24th. Finally, TD Cowen decreased their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $378.00.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $289.72 on Friday. The firm has a market cap of $16.98 billion, a PE ratio of 15.72, a PEG ratio of 1.15 and a beta of 0.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare has a 1-year low of $282.96 and a 1-year high of $423.92. The company has a fifty day moving average price of $339.60 and a 200 day moving average price of $332.51.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. During the same period in the prior year, the business posted $5.65 EPS. The company’s quarterly revenue was up 18.7% on a year-over-year basis. Research analysts predict that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Innealta Capital LLC bought a new stake in Molina Healthcare in the second quarter worth about $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at approximately $40,000. AM Squared Ltd purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at approximately $59,000. UMB Bank n.a. lifted its stake in shares of Molina Healthcare by 96.2% during the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after buying an additional 101 shares in the last quarter. Finally, Mather Group LLC. purchased a new stake in shares of Molina Healthcare during the 1st quarter valued at approximately $123,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.